Our Strategy: Delivering on Our Mission
Financial Update /// Strategic Priorities /// Our Divisions
At Bayer, our mission is straightforward: Health for all, Hunger for none. As a global leader in health and nutrition, we are committed to tackling the pressing challenges of our time, including a growing and aging population and the strain on our planet's ecosystems. We have reimagined our entire operating model to ensure that we stay focused on our mission while driving sustainable growth and value for our customers, employees, and stakeholders.
Our Commitment to Health and Nutrition
As the global population grows and ages, the demand for sufficient food and better healthcare becomes increasingly urgent. We are dedicated to improving the quality of life for people worldwide by providing innovative health solutions and sustainable agricultural practices.
Our efforts focus on:
- Preventing, alleviating, and treating diseases.
- Ensuring a reliable supply of high-quality food, feed, and plant-based raw materials.
- Enhancing access to nutrition and healthcare while reducing our organization’s ecological footprint and that of agriculture as a whole.
By leveraging innovation and digitalization, we aim to create value for customers, shareholders, and employees while operating sustainably and fulfilling our social and ethical responsibilities. At Bayer, employees passionate about innovation find excellent opportunities to grow and thrive. Our strategy is dynamic, continuously reviewed to remain agile in the face of economic and political changes.
Strategy and Financial Update
Our Strategic Priorities
At the Capital Markets Day 2024 CEO Bill Anderson outlined several priorities that the company is addressing.
Pharma Pipeline Development: We are committed to driving breakthrough innovations for patients facing high unmet medical needs. Our pharma pipeline is central to our strategy, enabling us to bring innovative treatments to market that improve health outcomes globally.
Strengthening our financial position: We are focused on lowering debt levels, allowing us to invest more in innovation and regain flexibility. We strive to be a reliable partner in the financial markets.
Litigation Management: Bayer is pursuing several measures to manage and mitigate the risks of Roundup™ litigation in the U.S. Based on decades of science and worldwide regulatory assessments that continue to support Roundup’s safety and non-carcinogenicity, we are confident that we can bring this litigation to an end. We are also managing and mitigating the U.S. PCB litigation risk.
Crop Science Profitability (added to list end of 2024): We aim to boost the profitability of our Crop Science division by developing sustainable agricultural solutions that support farmers and contribute to global food security. Regenerative agriculture forms our vision for the future of farming. Bayer aims to launch ten blockbuster products in the next ten years to support farmers worldwide.
Dynamic Shared Ownership (DSO): We have reimagined our entire operating model to ensure that our mission remains at the heart of everything we do. DSO fosters collaboration and shared accountability, empowering our teams to innovate and respond effectively to global challenges. This model enables us to deliver faster and more impactful solutions for farmers, patients, and consumers.
Sustainable Growth and Action: Core Components of Our Strategy
At Bayer, we understand that growth, profitability, and sustainability must go hand in hand. We are proud to contribute to the United Nations’ Sustainable Development Goals (SDGs) and are committed to taking science-based climate action throughout our value chain. Our focus on sustainability not only protects our planet but also strengthens our business for the future Sustainability shapes our corporate values and guides how we operate our businesses.
With longer life expectancy and an increase in chronic diseases, there is a growing need for innovative healthcare solutions. Bayer is committed to developing treatments that make a meaningful difference in patients’ lives, focusing on areas like women's health, cardiology, oncology, hematology, and ophthalmology. Our division also includes the Radiology business unit, further enhancing our impact. We also invest in the next generation of medicines like cell and gene therapies.
Agriculture is at the heart of solving global challenges like climate change, limited natural resources, and a growing population. By combining modern science with farmers’ ingenuity, we deliver sustainable innovations that help farmers grow enough food while protecting the planet. At Bayer, we believe feeding the world and restoring the planet should go hand in hand.
Globally, healthcare systems are strained, making access to healthcare difficult or even impossible for some individuals. Our human-centric approach begins with a deep understanding of people’s unmet needs, driving innovation that empowers them to take better care of their own health. With a diverse portfolio of over 170 trusted consumer health brands, Bayer delivers solutions across dermatology, nutritional supplements, pain management, cardiovascular risk prevention, digestive health, and care for coughs, colds, and allergies.
